Assess whether integration costs were sandbagged in the CIM (5de5a1)

Situation

In a roll-up of three regional service companies, regulatory-approval critical-path calendar is the evidence after add-backs that are just delayed opex. Buy-side QoE lead has to pick Proceed or Reprice for this M&A Due Diligence People and Contracts close using regulatory-approval critical-path calendar.

Decision

Buy-side QoE lead in a roll-up of three regional service companies must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after add-backs that are just delayed opex.

Hypotheses to test

• Add-backs that are just delayed opex is noise around an already-controlled People and Contracts process in a roll-up of three regional service companies, given regulatory-approval critical-path calendar.
• Add-backs that are just delayed opex is the event in regulatory-approval critical-path calendar that forces Proceed for buy-side QoE lead under M&A Due Diligence.
• Regulatory-approval critical-path calendar shows a one-file miss after add-backs that are just delayed opex, not a People and Contracts program failure.
• Regulatory-approval critical-path calendar cannot decide integration costs were sandbagged yet after add-backs that are just delayed opex; hold is the only M&A Due Diligence close a roll-up of three regional service companies can defend.

Analysis required

• Map reps, earnout mechanics, and integration risk a roll-up of three regional service companies would inherit.
• Tie quality-of-earnings, working-capital, and contingent items in regulatory-approval critical-path calendar to integration costs were sandbagged.
• Name the document buy-side QoE lead still needs before signing.
• For this M&A Due Diligence People and Contracts file, read regulatory-approval critical-path calendar against add-backs that are just delayed opex and write the one fact that would move integration costs were sandbagged for buy-side QoE lead.

Recommendation

Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / People and Contracts packet (regulatory-approval critical-path calendar after add-backs that are just delayed opex). Lead with the M&A Due Diligence option regulatory-approval critical-path calendar can support after add-backs that are just delayed opex, then the two facts that force it, then the Monday action for buy-side QoE lead in a roll-up of three regional service companies.